NIH-supported scientists used lab-grown human lung cells to study the cells' response to infection by a novel human coronavirus (called nCoV) and compiled information about which genes are significantly disrupted in early ...
Apr 30, 2013
0
0
Shingles vaccine is associated with reduction in both postherpetic neuralgia and herpes zoster, but uptake in the US is low.
Apr 9, 2013
0
0
A rising percentage of parents say they won't have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations, a study by Mayo ...
Mar 18, 2013
1
0
Poor diet and lifestyle choices set the stage for obesity and diabetes, but the immune system plays a relatively underappreciated role in accelerating this process. Metabolic changes in fat cells stimulate the release of ...
Mar 15, 2013
0
0
Seasonal epidemics of influenza result in nearly 36,000 deaths annually in the United States, according to the Centers for Disease Control. Current vaccines against the influenza virus elicit an antibody response specific ...
Mar 14, 2013
1
0
For HIV-infected patients whose disease is well-controlled by modern treatment, the risk of death is not significantly higher than in the general population, according to a study published in AIDS, official journal of the ...
Mar 11, 2013
0
0
Monash Institute of Medical Research scientists have found a protein in the female reproductive tract that protects against sexually transmitted diseases (STIs) such as chlamydia and herpes simplex virus (HSV).
Feb 28, 2013
0
0
Researchers at Georgia Regents University Cancer Center are investigating a new avenue of treatment to help boost poor pancreatic cancer survival rates.
Feb 12, 2013
0
0
New research from the Children's Outcomes Research Program at Children's Hospital Colorado shows that timely reminders by state or local health departments are more effective at increasing immunization rates among preschool ...
Jan 7, 2013
0
0
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
Dec 3, 2012
0
1
